Impact Evaluation of a Targeted mHealth Intervention to Improve Uptake of Postpartum Contraception in Kenya
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Postpartum Family Planning
- Sponsor
- Jacaranda Health
- Enrollment
- 4190
- Locations
- 1
- Primary Endpoint
- Use of postpartum family planning at 3 months
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The goal of this study is to explore approaches to improve postpartum contraceptive counseling, information, and uptake through a collaboration between the Harvard Chan School, Rutgers School of Public Health, Jacaranda Health, Jhpiego, and IPSOS, leveraging an existing mobile health platform for intervention delivery and Jacaranda's established partnership with the Kenyan Ministry of Health, county health offices and public maternity hospitals.
Jacaranda's PROMPTS mHealth platform has reached over two million pregnant women and new mothers, providing them with needed, tailored information about prenatal and postpartum health along with access to a mobile helpdesk to triage users' questions. Using a targeted human-centered-design process with early postpartum mothers, we developed targeted messaging around family planning and contraceptive method options, with the goal of integrating this new content into Jacaranda's PROMPTS platform. We will conduct a randomized controlled trial with pregnant women engaged with the PROMPTS platform to determine the impact of the intervention package on information and utilization of postpartum contraception. If proven effective, the results of this intervention will be integrated into Jacaranda's PROMPTS system at full scale.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 15 and over,
- •Pregnant at 7-8 months gestation,
- •Consented to be enrolled in the PROMPTS text-messaging platform and who have provided informed consent to be part of this research study
- •Have access to a mobile phone
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Use of postpartum family planning at 3 months
Time Frame: 3 months
The outcome is a binary variable, set to 1 if a participant reports using any modern family planning method (including Lactational Amenorrhea Method (LAM)) at the time of the survey. The modern methods considered will include sterilization (both male and female), implants, Intrauterine Device (IUD), injectables, oral contraceptives (pill), condoms (both male and female), diaphragm, foam/jelly, and LAM.
Use of postpartum family planning at 6 months
Time Frame: 6.5 months
The outcome is a binary variable, assigned a value of 1 if a participant reports using any modern family planning method, excluding LAM, at the time of the survey. The modern methods considered include sterilization (both male and female), implant, IUD, injectables, oral contraceptives (pill), condoms (both male and female), diaphragm, foam, and jelly.
Secondary Outcomes
- Discussion of FP at any prenatal visit(3 months postpartum)
- Reproductive empowerment: health care provider communication(3 and 6.5 months postpartum)
- Knowledge of return to fertility(3 months postpartum)
- Intended duration of continued family planning method use(3 and 6.5 months postpartum)
- Time to take-up of most effective methods(0-6.5 months postpartum)
- Knowledge of safe birth spacing(3 months postpartum)
- Intention to continue family planning method(3 and 6.5 months postpartum)
- Short interpregnancy interval(3 and 6.5 months postpartum)
- Discussion of FP at any postnatal visit(3 months postpartum)
- Knowledge of lactational amenorrhea (LAM) method(3 months postpartum)
- Method satisfaction(3 and 6.5 months postpartum)
- Uptake of most effective family planning methods(3 and 6.5 months postpartum)
- Desired pregnancy spacing of two years or more(3 months postpartum)